Related Experiment Video
Updated: May 13, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
MUC4 as a diagnostic marker in cancer
Subhankar Chakraborty1, Maneesh Jain, Aaron R Sasson
1University of Nebraska Medical Center, Eppley Institute for Research in Cancer, Department of Biochemistry and Molecular Biology, 984525 Nebraska Medical Center, Omaha, NE 68198-5870, USA +1 402 559 5455 ; +1 402 559 6650 ; sbatra@unmc.edu.
Mucin 4 (MUC4) expression is a specific marker for epithelial tumors and early dysplasia. Its detection in serum or blood may offer a new diagnostic biomarker for various cancers.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Mucins are glycoproteins with recognized roles in cancer diagnosis, prognosis, and therapy.
- Aberrant MUC4 expression is observed in multiple carcinomas, including pancreatic, breast, and lung cancers.
Purpose of the Study:
- This review evaluates the diagnostic and prognostic potential of MUC4 expression patterns in various cancers.
Main Methods:
- Review of literature on MUC4 expression in different cancer types.
- Analysis of MUC4's role as a diagnostic and prognostic marker.
Main Results:
- MUC4 expression is a specific marker for epithelial tumors.
- MUC4 expression positively correlates with tumor differentiation.
- MUC4 is expressed in early dysplastic lesions preceding malignancies, such as pancreatic cancer.
Conclusions:
- MUC4 is a specific marker for epithelial tumors and early dysplasia.
- MUC4 detection in serum or peripheral blood mononuclear cells suggests potential as a novel diagnostic biomarker.
- MUC4 holds promise for bedside diagnostic applications in high-risk individuals and cancer patients.
More Related Videos
15:17Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019